Cargando…

Diagnosing the severity of dry eye: a clear and practical algorithm

Dry eye disease (DED) is a distressing ocular condition. Due to its multifactorial nature, clinical and biological signs of DED can be inconsistent and sometimes discordant with symptomatology. Consequently, no gold-standard model for determining DED severity exists. This can impact treatment decisi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baudouin, Christophe, Aragona, Pasquale, Van Setten, Gysbert, Rolando, Maurizio, Irkeç, Murat, Benítez del Castillo, José, Geerling, Gerd, Labetoulle, Marc, Bonini, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145432/ https://www.ncbi.nlm.nih.gov/pubmed/24627252 http://dx.doi.org/10.1136/bjophthalmol-2013-304619

Ejemplares similares

Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting
por: Baudouin, Christophe, et al.
Publicado: (2017)

Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
por: Baudouin, Christophe, et al.
Publicado: (2016)

The Enduring Experience in Dry Eye Diagnosis: A Non-Interventional Study Comparing the Experiences of Patients Living With and Without Sjögren’s Syndrome
por: Figueiredo, Francisco C., et al.
Publicado: (2021)

Dry Eye Etiology: Focus on Friction
por: van Setten, Gysbert Botho, et al.
Publicado: (2020)

Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered
por: van Setten, Gysbert-Botho
Publicado: (2020)

Special Issue “Managing Dry Eye Disease over Time: An Italian Consensus Conference”
por: Aragona, Pasquale, et al.
Publicado: (2022)

Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
por: Labetoulle, Marc, et al.
Publicado: (2022)

The Effects of High Molecular Weight Hyaluronic Acid Eye Drop Application in Environmental Dry Eye Stress Model Mice
por: Kojima, Takashi, et al.
Publicado: (2020)

Management of inflammation in dry eye disease: Recommendations from a European panel of experts
por: Messmer, Elisabeth M, et al.
Publicado: (2022)

Dealing with the Persistent Pathogenic Issues of Dry Eye Disease: The Importance of External and Internal Stimuli and Tissue Responses
por: Rolando, Maurizio, et al.
Publicado: (2023)

Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017)

Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017)

The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial
por: van Setten, Gysbert-Botho, et al.
Publicado: (2020)

Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review
por: Aragona, Pasquale, et al.
Publicado: (2021)

Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey
por: Boboridis, Kostas G, et al.
Publicado: (2023)

Iatrogenic Dry Eye Disease: Dealing with the Conundrum of Post-Cataract Discomfort. A P.I.C.A.S.S.O. Board Narrative Review
por: Mencucci, Rita, et al.
Publicado: (2021)

Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study
por: Labetoulle, Marc, et al.
Publicado: (2018)

High Molecular Weight Hyaluronan Promotes Corneal Nerve Growth in Severe Dry Eyes
por: van Setten, Gysbert-Botho, et al.
Publicado: (2020)

Safety and Tolerability of an Eye Drop Based on 0.6% Povidone–Iodine Nanoemulsion in Dry Eye Patients
por: Oliverio, Giovanni William, et al.
Publicado: (2021)

Ocular Surface Allostasis—When Homeostasis Is Lost: Challenging Coping Potential, Stress Tolerance, and Resilience
por: van Setten, Gysbert-Botho
Publicado: (2023)

Defining Dry Eye from a Clinical Perspective
por: Tsubota, Kazuo, et al.
Publicado: (2020)

Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program
por: Pisella, Pierre-Jean, et al.
Publicado: (2018)

The Management of Dry Eye Disease: Proceedings of Italian Dry Eye Consensus Group Using the Delphi Method
por: Aragona, Pasquale, et al.
Publicado: (2022)

Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops
por: Beck, Ria, et al.
Publicado: (2019)

Dry Eye Disease: What Is the Role of Vitamin D?
por: Rolando, Maurizio, et al.
Publicado: (2023)

A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye
por: Baudouin, Christophe, et al.
Publicado: (2017)

MSC Transplantation Improves Lacrimal Gland Regeneration after Surgically Induced Dry Eye Disease in Mice
por: Dietrich, Jana, et al.
Publicado: (2019)

Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies
por: Leonardi, Andrea, et al.
Publicado: (2019)

Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system
por: Li, Jinyang, et al.
Publicado: (2012)

Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017)

Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment
por: Geerling, Gerd, et al.
Publicado: (2022)

Dry eye module – An application intelligence platform for diagnosing and monitoring dry eye disease
por: Iyer, Geetha, et al.
Publicado: (2023)

Capsazepine decreases corneal pain syndrome in severe dry eye disease
por: Fakih, Darine, et al.
Publicado: (2021)

Ocular Surface Epithelial Thickness Evaluation in Dry Eye Patients: Clinical Correlations
por: Liang, Qingfeng, et al.
Publicado: (2016)

Effect of artificial tears on dynamic optical quality in patients with dry eye disease
por: Wei, Zhenyu, et al.
Publicado: (2022)

Proinflammatory Markers, Chemokines, and Enkephalin in Patients Suffering from Dry Eye Disease
por: Nicolle, Pierre, et al.
Publicado: (2018)

Performance and Safety of a Sodium Hyaluronate Tear Substitute with Polyethylene Glycol in Dry Eye Disease: A Multicenter, Investigator-Masked, Randomized, Noninferiority Trial
por: Labetoulle, Marc, et al.
Publicado: (2022)

Commercially Available Eye Drops Containing Trehalose Protect Against Dry Conditions via Autophagy Induction
por: Hernandez, Eva, et al.
Publicado: (2021)

TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
por: Fakih, Darine, et al.
Publicado: (2020)

Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
por: Aragona, Pasquale, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_abapo0t5jt5fjp46mlk94aottj